HRI provides a comprehensive network of treatment services to individuals, 18 years
and older, impacted by drug and alcohol abuse. We offer both residential and outpatient
services, including the following:
• Methadone Maintenance (Outpatient)
• Methadone Detox (Outpatient)
• Buprenorphine Detox (Residential) – see details below
• Residential Therapeutic Care
• Individual Counseling
• Group Counseling
• Psychiatric Evaluations
• Physical Examinations
• HIV Pre/Post Testing & Counseling
• Education & Support Services for Families
• Assessments & Referrals
HRI’s Buprenorphine Detoxification Program for Addiction Treatment
The Buprenorphine Program at Human Resources specializes in the use of Suboxone in the treatment of individuals addicted to opiates. We currently provide residential detoxification at our Willow Oaks Facility in Cartersville,VA. We launched our Buprenorphine Outpatient Detoxification Program on October 4, 2007 at our Opioid Treatment Facility in Richmond, VA.
Patients are transitioned from their current substance of abuse onto Suboxone. The stabilization and detox phase takes place after a thorough evaluation by our multidisciplinary team. Our team includes a psychologist, an internist, an addictionologist, nurses and clinical staff. Each team member lends a special expertise in dealing with opiate dependence and transition through the Buprenorphine detoxification process.
What Is Buprenorphine?
Buprenorphine is the first oral medication approved in the U.S. that physicians can prescribe in their offices to people who are dependent or addicted to opiates, such as pain medication and heroin. Buprenorphine blocks the effects of other opiates, eliminates cravings and prevents withdrawal symptoms such as pain and nausea. Patients can be placed on maintenance or elect detoxification.
Terms Used in Buprenorphine Treatment
Many of the terms used in the treatment of individuals addicted to opiates can seem quite foreign. Following is a short list to help you.
Buprenorphine: is a medication used to treat adults addicted to or dependent on opiates. At Human Resources, Inc. it is available in oral form (Suboxone:sublingual tablets or sublingual film strips). Buprenorphine blocks the effects of other opiates and eliminates cravings and symptoms of withdrawal.
Induction: This is the transition phase of Buprenorphine therapy.
Stabilization: In this phase of treatment the patient and doctors determine the correct dose of Buprenorphine required to eliminate cravings and signs and symptoms of withdrawal that the patient is experiencing.
Detoxification: During this process all opiates are withdrawn. This usually involves a gradual decrease in the amount of Buprenorphine that the patient is taking.
Suboxone: Tablet or film strip containing Buprenorphine and naloxone.